282 related articles for article (PubMed ID: 18922830)
21. Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias.
Morgan MA; Reuter CW
Ann Hematol; 2006 Mar; 85(3):139-63. PubMed ID: 16391911
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and clinical burden of acute myeloid leukemia.
Redaelli A; Lee JM; Stephens JM; Pashos CL
Expert Rev Anticancer Ther; 2003 Oct; 3(5):695-710. PubMed ID: 14599092
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acute myeloid leukemia in older patients.
Roboz GJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
[TBL] [Abstract][Full Text] [Related]
24. All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients.
Di Febo A; Laurenti L; Falcucci P; Tosti ME; Fianchi L; Pagano L; Leone G
Am J Ther; 2007; 14(4):351-5. PubMed ID: 17667210
[TBL] [Abstract][Full Text] [Related]
25. Current therapeutic strategies for acute myeloid leukaemia.
Kolitz JE
Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
27. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia.
Kuendgen A; Schmid M; Schlenk R; Knipp S; Hildebrandt B; Steidl C; Germing U; Haas R; Dohner H; Gattermann N
Cancer; 2006 Jan; 106(1):112-9. PubMed ID: 16323176
[TBL] [Abstract][Full Text] [Related]
29. Has there been progress in the treatment of older patients with acute myeloid leukemia?
Erba HP
Best Pract Res Clin Haematol; 2010 Dec; 23(4):495-501. PubMed ID: 21130413
[TBL] [Abstract][Full Text] [Related]
30. Novel therapeutic agents in acute myeloid leukemia.
Stone RM
Exp Hematol; 2007 Apr; 35(4 Suppl 1):163-6. PubMed ID: 17379102
[TBL] [Abstract][Full Text] [Related]
31. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
32. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].
Chen YJ; Zhang LQ; Li XL; Zhao XL; Wu DS; Shu YG; Chen FP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):245-51. PubMed ID: 18382060
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.
Ferrara F; Fazi P; Venditti A; Pagano L; Amadori S; Mandelli F
Hematol Oncol; 2008 Jun; 26(2):104-7. PubMed ID: 18271064
[TBL] [Abstract][Full Text] [Related]
35. Clinical trials in adult AML.
Stock W
Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
[No Abstract] [Full Text] [Related]
36. Present status and perspectives regarding the therapeutic strategy for acute myeloid leukemia, non-Hodgkin's lymphoma and multiple myeloma in the elderly.
Ohta M
Geriatr Gerontol Int; 2009 Jun; 9(2):115-23. PubMed ID: 19740353
[TBL] [Abstract][Full Text] [Related]
37. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
Muranyi AL; Dedhar S; Hogge DE
Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
[TBL] [Abstract][Full Text] [Related]
38. Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.
Gotlib J
Curr Hematol Rep; 2005 Jan; 4(1):77-84. PubMed ID: 15610664
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia in the elderly.
Dombret H; Raffoux E; Gardin C
Semin Oncol; 2008 Aug; 35(4):430-8. PubMed ID: 18692693
[TBL] [Abstract][Full Text] [Related]
40. Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia.
Roboz GJ
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S22-4. PubMed ID: 18760707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]